Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -20.53M
March 31, 2026 -25.83M
December 31, 2025 -15.94M
September 30, 2025 -25.78M
June 30, 2025 -27.91M
March 31, 2025 -35.10M
December 31, 2024 -24.38M
September 30, 2024 -27.53M
June 30, 2024 -27.60M
March 31, 2024 -30.79M
December 31, 2023 -27.21M
September 30, 2023 -16.91M
June 30, 2023 -23.75M
Date Value
March 31, 2023 -34.43M
December 31, 2022 -29.30M
September 30, 2022 -34.18M
June 30, 2022 -36.14M
March 31, 2022 82.56M
December 31, 2021 -41.20M
September 30, 2021 -39.84M
June 30, 2021 -29.65M
March 31, 2021 -24.06M
December 31, 2020 -16.63M
September 30, 2020 -13.73M
June 30, 2020 -11.15M
March 31, 2020 -9.583M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. -14.15M
Exicure, Inc. -0.887M
Absci Corp. -27.56M
Celularity, Inc. 1.447M
Cardio Diagnostics Holdings, Inc. -1.389M